SCHEMBL17655860

SCHEMBL17655860

c1ccc(-c2cc(-c3ccc(-c4cccc5cc(-c6ccc(-c7nc(-c8ccccc8)cc(-c8ccccc8)n7)cc6)ccc45)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
ALDH1A1 P00352 7/20 0.51
HPGD P15428 7/20 0.51
MAPT P10636 6/20 0.51
NTSR1 P30989 1/20 0.51
KDM4E B2RXH2 4/20 0.49
LMNA P02545 2/20 0.49
GLA P06280 1/20 0.49
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
CYP1A1 P04798 1/20 0.44
CYP1B1 Q16678 1/20 0.44
ENPP3 O14638 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16716522 1.00 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL16716616 1.00 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655913 0.98 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655845 0.98 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655839 0.98 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655977 0.96 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17754458 0.95 MEN1 (0.51) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655933 0.95 MEN1 (0.50) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655883 0.94 MEN1 (0.53) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL17655936 0.94 MEN1 (0.54) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9882145-B2 Hetero ring compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2018-01-30 US disclosed
US-9882145-B2 Hetero ring compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2018-01-30 US disclosed
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-05-19 US disclosed
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2016-05-19 US disclosed
EP-3002282-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG Chem, Ltd. (KR) 2016-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160141514-A1 HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CRY2, PER2 MEN1 2891/4885KMT2A 530/4885ALDH1A1 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.